Search

everythinglearnresearchcommunity

for

Search:↓

Both finasteride and metformin effectively treat PCOS by reducing hormone levels and insulin resistance.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Higher cortisol levels are linked to poor coping, while higher DHEA levels are linked to job confidence.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.